Alex is currently the Head of US/China Business Development with Zuellig Pharma, a distribution and commercialization company with $16 billion annual revenue and approximately 15,000 employees in 13 markets in the APAC region. Prior to joining Zuellig, Alex had been with Pfizer, Merck KGaA and Abbott as well as a Shanghai-based start-up biotech company in various positions including Pfizer Anti-infective Global Franchise Leader and Abbott POCT Diagnostics APAC Head. Alex has worked in diverse geographic locations in Canada, US, Japan, Vietnam, Singapore and China. With his past experiences as Managing Director of Merck Vietnam as well as in regional positions with focus on SE Asia, Alex understands the area intimately well.